Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells

Histone deacetylase (HDAC) inhibitors are promising anticancer drugs but their effect on tumor treatment has been disappointing mainly due to the acquisition of HDAC inhibitor resistance. However, the mechanis...

Source: Biological Research - October 1, 2020 Category: Biomedical Science Authors: Won Chan Hwang, Dong Woo Kang, Youra Kang, Younghoon Jang, Jung-Ae Kim and Do Sik Min Tags: Research article Source Type: research